It is owned and operated by the Chiefs Development Group. Prospera Centre includes a main arena with a seating capacity of 5,000. The second arena is designed for community use and accommodates approximately 300 seats.
Breo Ellipta is a prescription medication used to decrease lung inflammation and open its passageways. It is a combination of fluticasone and vilanterol and comes in two strengths, 100mcg/25mcg and 200mcg/25mcg (fluticasone/vilanterol), with prices for one inhaler with sixty blisters ranging from $290 to $380.
Canada Approves Breo Ellipta for Adults With Asthma. Canadian regulators have approved the dry powder combination of fluticasone furoate and vilanterol (Breo Ellipta, GlaxoSmithKline/Theravance) for once-a-day treatment of asthma in adults with reversible obstructive airways disease, GlaxoSmithKline announced last week.